EUVIMEDEUVIMED entdecken
Open Access

Association between blood methylmalonic acid and chronic kidney disease in the general US population: insights from multi-cycle National Health and Nutrition Examination Survey (NHANES)

Liang Wu, Dong-Yuan Chang, Ming-Hui Zhao, Sydney C W Tang, Min Chen

Annals of Translational Medicine · 2024-06 · 12 (3) · 47-47

DOI: 10.21037/atm-23-1930 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Translational Medicine, 2024-06. Verfasst von Liang Wu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Renal Division, Department of Medicine, Peking University First Hospital, Beijing, China. Die Arbeit wurde bisher 6-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chronic kidney disease (CKD) is significantly influenced by mitochondrial dysfunction (MD). Previous research suggests that methylmalonic acid (MMA) is involved in MD. Consequently, we aimed to investigate associations between blood MMA level and the prevalence of CKD as well as mortality in patients with CKD.

Methods

The study included 23,587 individuals from National Health and Nutrition Examination Survey (NHANES). The NHANES datasets from 1999-2004 and 2011-2014 were utilized as separate primary and validation subsets. There were 3,554 patients with CKD. The association of blood MMA level with the prevalence of CKD was investigated using weighted logistic regression. Meanwhile, we employed weighted Cox regression models to evaluate the association between blood MMA level and all-cause mortality in patients with CKD.

Results

Blood MMA levels had a significant positive association with urinary albumin-to-creatinine ratio (β=45.29, P=0.01) and negative association with estimated glomerular filtration rate (β=-15.27, P

Schlagwörter

Stichwörter der Autor:innen

Methylmalonic acid (MMA)chronic kidney disease (CKD)mortality, mitochondrial dysfunction (MD)

Autor:innen und Institutionen

  • Renal Division, Department of Medicine, Peking University First Hospital, Beijing, China.
  • Institute of Nephrology, Peking University, Beijing, China.
  • Key Laboratory of Renal Disease, Ministry of Health of China, Beijing, China.
  • Key Laboratory of Chronic Kidney Disease Prevention and Treatment (Peking University), Ministry of Education, Beijing, China.
  • Research Units of Diagnosis and Treatment of Immune-mediated Kidney Diseases, Chinese Academy of Medical Sciences, Beijing, China.
  • Division of Nephrology, Department of Medicine, University of Hong Kong, Hong Kong, China.

Zitieren

APA

Wu, L., Chang, D. Y., Zhao, M. H., Tang, S. C. W., & Chen, M. (2024). Association between blood methylmalonic acid and chronic kidney disease in the general US population: insights from multi-cycle National Health and Nutrition Examination Survey (NHANES). Annals of Translational Medicine, 12(3), 47-47. https://doi.org/10.21037/atm-23-1930

Vancouver

Wu L, Chang DY, Zhao MH, Tang SCW, Chen M. Association between blood methylmalonic acid and chronic kidney disease in the general US population: insights from multi-cycle National Health and Nutrition Examination Survey (NHANES). Annals of Translational Medicine. 2024;12(3):47-47. doi:10.21037/atm-23-1930

BibTeX
@article{Wu2024,
  author = {Wu, Liang and Chang, Dong-Yuan and Zhao, Ming-Hui and Tang, Sydney C W and Chen, Min},
  title = {Association between blood methylmalonic acid and chronic kidney disease in the general US population: insights from multi-cycle National Health and Nutrition Examination Survey (NHANES)},
  journal = {Annals of Translational Medicine},
  year = {2024},
  volume = {12},
  number = {3},
  pages = {47--47},
  doi = {10.21037/atm-23-1930}
}
Kostenlos starten →